Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




New Findings Implicate Circular RNA in the Development of Neurodegenerative Diseases

By LabMedica International staff writers
Posted on 28 Sep 2014
A recent paper described new findings that shed light on the production and function of circular RNA molecules (circRNA) in animal neuronal tissue.

CircRNA is a type of noncoding RNA that, unlike linear RNA, forms a covalently closed continuous loop. More...
In circular RNA the 3' and 5' ends normally present in an RNA molecule have been joined together. This feature confers numerous properties to circular RNAs, many of which have only recently been identified. Though many of these circular RNAs arise from otherwise protein coding genes, circular RNAs produced in the cell have not been shown to code for proteins.

Investigators at The Hebrew University of Jerusalem (Israel) reported in the September 18, 2014, online edition of the journal Molecular Cell that animal circRNAs were generated co-transcriptionally and that their production rate was mainly determined by intronic sequences—filler DNA that separates coding regions on the chromosomes.

The investigators demonstrated that the process of circularization and that of normal splicing competed against each other, and that these mechanisms were tissue specific and conserved in animals. To further refine these findings, they concentrated on the gene for the protein muscleblind (muscleblind-like splicing regulator 1), which generates circularized RNA in flies and humans. They found that this circRNA (circMbl) and its flanking introns contained conserved muscleblind binding sites, which were strongly and specifically bound by muscleblind. Modulation of muscleblind levels strongly affected circMbl biosynthesis, and this effect was dependent on the muscleblind binding sites.

Since defects in muscleblind function have been linked to the severe degenerative disease myotonic dystrophy and since high levels of circRNAs are found in brain tissue, it may be that these molecules play a role in development of myotonic dystrophy and possibly other neurodegenerative diseases.

Senior author Dr. Sebastian Kadener, senior lecturer in biological chemistry at The Hebrew University of Jerusalem, said, "This research is significant from several perspectives. By mapping how circRNAs are produced, it helps advance our understanding of general molecular biology. In addition, it might be strongly relevant for understanding and eventually treating degenerative diseases both in muscle and the brain."

Related Links:

The Hebrew University of Jerusalem



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.